Converge Bio
2 known investors
Converge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies. The company provides AI solutions for target discovery, antibody design, protein manufacturing optimization, and biomarker discovery.
AI & Machine LearningBiotechDeep Tech
Investors · 2
In the news
- Trysignalbasetrysignalbase.com · 2026
- Israeli AI drug discovery co Converge Bio raises $25m - Globesen.globes.co.il · 2026
- Converge Bio Raises $25M in Series A Fundingfinsmes.com · 2026
- Converge Bio raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical companyprnewswire.com · 2026
- Converge Bio raises $25 million Series A to accelerate AI drug discovery | Ctechcalcalistech.com · 2026
- Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz | TechCrunchtechcrunch.com · 2026